文献速递白血病

急性髓系白血病的细胞周期状态免疫表型分析:与细胞遗传学、基因型和临床结局的关系

Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome.
PubMed 文献 · Br J Haematol · 2018-04-20

研究对181例急性髓系白血病(AML)患者的骨髓环钻活检标本进行免疫表型分析以确定白血病细胞周期状态,并与生物学特征及临床结局进行关联。结果显示初诊白细胞计数与未静息细胞比例、G1期后 cycling 细胞比例及 cycling 速度显著相关;NPM1突变而非FLT3内部串联重复与更高比例的G1期后细胞及更快的 cycling 速度显著相关;对标准阿糖胞苷和柔红霉素诱导化疗的耐药与较慢的 cycling 速度显著相关,复发率较高亦与较慢 cycling 速度相关。

要点

  • 初诊白细胞计数与未静息细胞比例、G1期后 cycling 细胞比例及 cycling 速度均显著相关(P < 0·0001)。
  • NPM1突变与更高比例的G1期后细胞(P = 0·002)和更快的 cycling 速度(P = 0·003)显著相关,FLT3ITD 无此关联。
  • 对标准阿糖胞苷和柔红霉素诱导化疗耐药与较慢的 cycling 速度显著相关(P = 0·0002)。

核心结论

  • AML细胞 cycling 速度与化疗反应之间存在关联,并有助于识别预后极差的一组患者。

研究设计与样本

  • 对181例急性髓系白血病(AML)患者的骨髓环钻活检标本进行免疫表型分析以确定细胞周期状态,并将结果与生物学特征及临床结局进行关联。

主要发现

  • 患者间存在相当大的异质性。
  • 初诊白细胞计数与未静息细胞比例(P < 0·0001)、G1期后 cycling 细胞比例(P < 0·0001)及 cycling 速度(P < 0·0001)显著相关。
  • 急性早幼粒细胞白血病(APL)的细胞周期特征与非APL不同,符合分化程度更高、增殖潜能降低的表现,但非APL细胞遗传学风险组间未观察到显著差异。
  • NPM1突变而非FLT3内部串联重复(FLT3ITD)与更高比例的G1期后细胞(P = 0·002)及更快的 cycling 速度(P = 0·003)显著相关。
  • 对标准阿糖胞苷和柔红霉素诱导化疗的耐药与较慢的 cycling 速度显著相关(P = 0·0002),较高的复发率亦与较慢的 cycling 速度相关(P = 0·05),但与未静息细胞比例或活跃 cycling 细胞比例无关。

关键数值与推荐

  • 初诊白细胞计数与未静息细胞比例、G1期后 cycling 细胞比例及 cycling 速度的关联均 P < 0·0001。
  • NPM1突变与更高比例的G1期后细胞相关 P = 0·002,与更快的 cycling 速度相关 P = 0·003。
  • 对标准阿糖胞苷和柔红霉素诱导化疗耐药与较慢的 cycling 速度相关 P = 0·0002。
  • 较高的复发率与较慢的 cycling 速度相关 P = 0·05。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cell cycle status may play an important role in directing patient therapy. We therefore determined the cell cycle status of leukaemic cells by immunophenotypic analysis of bone marrow trephine biopsies from 181 patients with acute myeloid leukaemia (AML) and correlated the results with biological features and clinical outcome. There was considerable heterogeneity between patients. The presenting white cell count significantly correlated with the proportion of non-quiescent cells (P < 0·0001), of cycling cells beyond G1 (P < 0·0001) and the speed of cycling (P < 0·0001). Profiles in acute promyelocytic leukaemia (APL) differed from non-APL and were consistent with more differentiated cells with reduced proliferative potential, but no significant differences were observed between non-APL cytogenetic risk groups. NPM1 mutations but not FLT3 internal tandem duplication (FLT3ITD ) were significantly associated with a higher proportion of cells beyond G1 (P = 0·002) and faster speed of cycling (P = 0·003). Resistance to standard cytosine arabinoside and daunorubicin induction chemotherapy was significantly related to a slower speed of cycling (P = 0·0002), as was a higher relapse rate (P = 0·05), but not with the proportion of non-quiescent cells or actively cycling cells. These results show a link between the cycling speed of AML cells and the response to chemotherapy, and help to identify a group with a very poor prognosis.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Sellar RS, Gale RE, Khwaja A, et al. Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome. Br J Haematol. 2018. PMID: 29676467. doi:10.1111/bjh.15211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。